Palisade Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Palisade Bio generated cash of -$11,133,000, which is more than the previous year. Cash used in financing activities reached the amount of $11,186,000 last year. Net change in cash is therefore $49,000.
Cash Flow
| 2014 | -11.70M | -15.56M | 22.94M |
|---|---|---|---|
| 2015 | -18.93M | 7.24M | 3.88M |
| 2016 | -15.61M | 2.35M | 23.73M |
| 2017 | -13.41M | -94.04K | 4.99M |
| 2018 | -7.69M | 4.99M | 1.81M |
| 2019 | -7.25M | 3.92M | 6.58M |
| 2020 | -4.76M | -6K | 1.89M |
| 2021 | -14.77M | -54K | 24.60M |
| 2022 | -13.36M | -10K | 15.25M |
| 2023 | -11.13M | -4K | 11.18M |
PALI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 12.40M | 10.52M | 739K | 3.62M | 5.78M | 6.67M | 15.19M | 4.71M | 12.51M | 16.84M |
Operating activities | ||||||||||
Net income | -12.3M | -14.26M | -26.61M | -10.32M | -8.35M | -4.92M | -15.66M | -21.07M | -20.90M | -22.62M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4K | 3K | 2K | 3K | 143.85K | 185.80K | 289.20K | 337.50K | 345.46K | 348.63K |
Stock-based compensation expense | 624K | 1.03M | 1.89M | 2.01M | 3.32M | 1.09M | 1.76M | 0 | 2.95M | 0 |
| Deferred income tax benefit | 624K | 1.03M | 1.89M | 2.01M | 3.32M | 1.09M | 1.76M | 0 | 2.95M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 84K | -59K | 272.99K | 80.80K | -249.23K | -450.49K | 188.20K | 0 |
Inventories | 0 | 0 | -84K | -947K | 15.74K | 36.99K | -11.74M | -7.91M | 0 | 0 |
Accounts payable | -492K | 399K | -2.39M | 1.00M | -15.74K | -36.99K | -1.52M | 879.07K | -1.04M | 1.38M |
Cash generated by operating activities | -11.13M | -13.36M | -14.77M | -4.76M | -7.25M | -7.69M | -13.41M | -15.61M | -18.93M | -11.70M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -5M | -5M | -7.51M | -25.00M |
Investments In Property Plant And Equipment | -4K | -10K | 0 | -6K | 0 | -1.71K | -94.04K | -161.11K | -243.58K | -556.34K |
Acquisitions Net | 0 | 0 | -54K | 0 | 0 | 0 | 82.64K | 63.02K | 67.31K | 348.45K |
Cash generated by investing activities | -4K | -10K | -54K | -6K | 3.92M | 4.99M | -94.04K | 2.35M | 7.24M | -15.56M |
Financing activities | ||||||||||
Common Stock Issued | 9.41M | 14.40M | 25.04M | 1.17M | 6.55M | 1.82M | 8.73M | 28.11M | 6.00M | 21.26M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -391K | -790K | -183K | -27K | 36.42K | -13.76K | -3.74M | -4.38M | -1.27M | -2.10M |
Cash used in financing activities | 11.18M | 15.25M | 24.60M | 1.89M | 6.58M | 1.81M | 4.99M | 23.73M | 3.88M | 22.94M |
Net Change In Cash | 49K | 1.88M | 9.78M | -2.88M | -672.19K | -887.83K | -8.52M | 10.47M | -7.80M | -4.32M |
Cash at end of period | 12.45M | 12.40M | 10.52M | 739K | 5.11M | 5.78M | 6.67M | 15.19M | 4.71M | 12.51M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |